SHOULDER INNOVATIONS, INC. (SI) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US82537J1088
Price
21.08 USD
Market cap
182.83 m USD
P/E (2026)
–
P/S (2026)
–
Dividend yield
0.00 %
Net margin
–
Return on equity (ROE)
–
Return on assets (ROA)
–
SHOULDER INNOVATIONS, INC. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 47.32 m USD |
| Gross profit | 36.20 m USD |
| Operating income | -26.30 m USD |
| EBIT | -42.24 m USD |
| Net income | -40.36 m USD |
| Diluted EPS – continuing operations | -4.65 USD |
Full history since 2023, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About SHOULDER INNOVATIONS, INC.
Shoulder Innovations, Inc. engages in the provision of medical devices. It focuses on transforming the shoulder surgical care market. It also offers advanced implant systems for shoulder arthroplasty. The company was founded by Stephen B. Gunther and Michael DeVries in 2009 and is headquartered in Grand Rapids, MI.
More stocks
- Premia S.A. (PREMIA.AT)
- Staude Capital Global Value Fund Ltd (GVF.AX)
- SCI Pharmtech Inc (4119.TW)
- Kjell Group AB (KJELL.ST)
- Inversiones Doalca SOCIMI SA (YDOA.MC)
- Shandong Longertek Technology Co Ltd (300594.SZ)
- Kao Hsiung Chang Iron & Steel Corp (2008.TW)
- InflaRx N.V. (IFRX)
- Hwacom Systems (6163.TWO)
- Yarrow Bioscience, Inc. (YARW)
- ThredUp Inc. (TDUP)
- NEXTEEL Co., Ltd. (092790.KS)
Not investment advice. All data without warranty, price as of 12.11.2026. Details in the risk notice.